| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,683 |
5,342 |
$165K |
| 99243 |
|
1,395 |
918 |
$80K |
| 17004 |
|
2,336 |
1,206 |
$78K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,792 |
3,301 |
$63K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,672 |
1,589 |
$62K |
| 99242 |
|
854 |
575 |
$37K |
| 11102 |
|
1,335 |
576 |
$25K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,848 |
694 |
$11K |
| 11100 |
|
541 |
397 |
$10K |
| 11106 |
|
310 |
137 |
$9K |
| 11101 |
|
337 |
216 |
$5K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
215 |
98 |
$4K |
| 17000 |
|
186 |
91 |
$2K |
| 11107 |
|
79 |
39 |
$2K |
| 11103 |
|
165 |
54 |
$1K |
| 11901 |
|
183 |
74 |
$1K |
| 96401 |
|
24 |
13 |
$811.69 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
389 |
161 |
$474.53 |
| 17110 |
|
21 |
13 |
$330.68 |
| 17003 |
|
23 |
12 |
$195.67 |
| J3590 |
Unclassified biologics |
119 |
52 |
$0.14 |
| J2357 |
Injection, omalizumab, 5 mg |
36 |
14 |
$0.04 |